An improved design of PCR primers for detection of human T cell receptor beta chain repertoire.

Molecular Biology Reports
Yuan OuPing Zhu

Abstract

Analysis of T cell receptor beta variable region (TCRBV) gene rearrangement is useful for clonal assessment of abnormal T cell proliferations in various diseases. However, most primer panels previously used can only amplify the third complementarity-determining region. Following IMGT database we established a panel of primers, which can amplify entire sequences of all functional TCRBV families. To confirm the usefulness of this panel of primers, we detected different TCRBV repertoires. In 15 healthy donors, most of the BV families were expressed and appeared as a Gaussian distribution. 13 acute myeloid leukemia patients showed monoclonal or oligoclonal changes of BV15 family, and some of them also had monoclonal or oligoclonal expansion of BV2, BV4, BV6 or BV13 families. In one patient after allo-hematopoietic stem cell transplantation, monoclonal proliferation of BV10 family occurred during graft-versus-host disease. In conclusion, this panel of primers improves our abilities to analyze TCRBV repertoire changes in related diseases.

References

Jun 8, 1999·Annual Review of Immunology·H LiR A Mariuzza
Mar 20, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Z W ChenN L Letvin
Jan 16, 2002·Current Opinion in Immunology·Markus G Rudolph, Ian A Wilson
Jan 11, 2003·Clinical and Diagnostic Laboratory Immunology·Monica KharbandaSavita Pahwa
Feb 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marcella SarzottiRebecca H Buckley
Jul 26, 2005·Journal of Immunological Methods·Jamie Leigh Brewer, Solveig Gronning Ericson
Nov 2, 2005·Protein Science : a Publication of the Protein Society·Hongmin LiYixin Li
Mar 23, 2006·Annual Review of Immunology·Markus G RudolphIan A Wilson
Aug 28, 2007·Molecular Immunology·Katherine KedzierskaPeter C Doherty
Jan 29, 2008·International Journal of Cancer. Journal International Du Cancer·Carolin LükingRalph Mocikat

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.